Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
07/28/2010
Trade Name:
Lastacaft Ophthalmic Solution
Generic Name or Proper Name (*):
alcaftadine
Indications Studied:
Prevention of itching associated with allergic conjunctivitis.
Label Changes Summary:
Safety and effectiveness in patiente 2 years were established in controlled clinical trials Safety and effectiveness in pediatric patients< 2 years have not been established New drug
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Vistakon Pharmaceuticals,
NNPS:
FALSE'
Therapeutic Category:
Antihistamine, topical
-
-